Presentation is loading. Please wait.

Presentation is loading. Please wait.

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis  Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,

Published byLudwik Wiktor Pawlak Modified over 5 years ago

Similar presentations

Presentation on theme: "Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis  Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,"— Presentation transcript:

1 Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis 
Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb, Tari Haahtela, MD, PhDc, Gunbjörn Aasand, MDd, Leif Rosenhall, MD, PhDe, Olle Zetterstrom, MD, PhDf, Aidan Byrne, BScg, Kate Champain, PhDg, Jackie Thirlwell, MScg, Giovanni Della Cioppa, MDg, Thomas Sandström, MD, PhDa  Journal of Allergy and Clinical Immunology  Volume 106, Issue 2, Pages (August 2000) DOI: /mai Copyright © 2000 Mosby, Inc. Terms and Conditions

2 Fig. 1 Average daily birch pollen counts and nasal symptom severity scores throughout the birch pollen season in Finland, Norway, and Sweden. Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2000 Mosby, Inc. Terms and Conditions

3 Fig. 2 Average daily nasal symptom severity scores (with SEs) over the entire postrandomization period (all randomized subjects in an intent-to-treat analysis). The baseline levels are not equal to the first point indicated in Fig 1 because baseline values were spread over a number of different dates. Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2000 Mosby, Inc. Terms and Conditions

Download ppt "Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis  Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,"

Similar presentations

Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia.

Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia.
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Recombinant allergen fragments as candidate preparations for allergen immunotherapy  Thomas Zeiler, MDa, Antti Taivainen, MD, PhDb, Marja Rytkönen, PhDa,

Recombinant allergen fragments as candidate preparations for allergen immunotherapy  Thomas Zeiler, MDa, Antti Taivainen, MD, PhDb, Marja Rytkönen, PhDa,
Immune function in cigarette smokers who quit smoking for 31 days

Immune function in cigarette smokers who quit smoking for 31 days
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis  Andrzej Bożek, MD, PhD, Krzysztof Kołodziejczyk, MD, PhD, Jerzy Jarząb,

Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis  Andrzej Bożek, MD, PhD, Krzysztof Kołodziejczyk, MD, PhD, Jerzy Jarząb,
Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis  Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis  Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.
Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc

Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc
Heredity, pet ownership, and confounding control in a population-based birth cohort  Catarina Almqvist, MD, PhDa,b, Ann-Charlotte Egmar, RNa, Marianne.

Heredity, pet ownership, and confounding control in a population-based birth cohort  Catarina Almqvist, MD, PhDa,b, Ann-Charlotte Egmar, RNa, Marianne.
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin) 

Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin) 
Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus–1 disease  Gail Shor-Posner, PhDa,

Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus–1 disease  Gail Shor-Posner, PhDa,
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis 

Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis 
The effect of omalizumab on nasal allergic inflammation

The effect of omalizumab on nasal allergic inflammation
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Similar presentations

Ads by Google